Patent · US Active

Method of diagnosing poor survival prognosis colon cancer using miR-103-2

US8338104B2 · kind B2 · utility

2Cited by

2References

18Claims

0Family size

Assignees

The Ohio State University Research Foundation · US
THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES, NATIONAL INSTITUTES OF HEALTH · US

Inventors

Carlo M. Croce · Philadelphia, US
Curtis C. Harris · Bethesda, US
Aaron J. Schetter · Silver Spring, US

Key dates

Filing date	Nov 15, 2011
Grant date	Dec 25, 2012
Priority date	—
Expiry date	Nov 15, 2031

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY10T436/143333
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

The present invention provides novel methods and compositions for the diagnosis and treatment of colon cancers. In particular, the present invention provides diagnostics and prognostics for colon (including colon adenocarcinoma) cancer patients, wherein the methods related to measuring miR levels can predict poor survival. The invention also provides methods of identifying inhibitors of tumorigenesis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.